Epilepsy, Tonic-Clonic: Clinical Trials

3 trials for Epilepsy, Tonic-Clonic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Recruiting 1

Follow Epilepsy, Tonic-Clonic: new trials by email Literature Review of Epilepsy, Tonic-Clonic trials Research Report on Epilepsy, Tonic-Clonic

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures
Oral Zonisamide Therapy - Epilepsies, Partial, Epilepsy, Tonic-Clonic
Phase 4RecruitingAffiliated Hospital of Nantong University302024-08-012025-05-13
IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures
Keppra, Fosphenytoin, Dilantin - Tonic-clonic Seizure
Phase 4CompletedEmory University1582007-07-012013-12-12
Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug
lamotrigine - Epilepsy, Tonic-Clonic
Phase 4CompletedGlaxoSmithKline1412000-12-012017-04-04

Narrower conditions

Seizures (2)  ·  Emergencies (1)  ·  Epilepsies, Partial (1)  ·  Epilepsy (1)

Broader conditions

Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Epilepsy, Generalized (3)  ·  Nervous System Diseases (3)  ·  Epilepsy (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Disease Attributes (1)  ·  Pathologic Processes (1)

Interventions

Lamotrigine (1)  ·  Levetiracetam (1)  ·  Phenytoin (1)  ·  fosphenytoin (1)

Sponsors

Affiliated Hospital of Nantong University (1)  ·  Emory University (1)  ·  GlaxoSmithKline (1)

Countries

United States (2)  ·  Argentina (1)  ·  Chile (1)  ·  China (1)  ·  Peru (1)

Top investigators

Debra Houry, MD (1)

Results publications

PMID 16344515